 |
|
|
| |
TURQUOISE-II: SVR12 RATE OF 92-96% IN 380 HEPATITIS C VIRUS GENOTYPE 1-INFECTED ADULTS WITH COMPENSATED CIRRHOSIS TREATED WITH ABT-450/r/ABT-267 AND ABT-333 PLUS RIBAVIRIN
|
| |
| |
Reported by Jules Levin
EASL 2014 April 9-13 London, UK
Fred Poordad, Christophe Hezode, Roger Trinh, Kris V Kowdley, Stefan Zeuzem, Kosh Agarwal, Mitchell L Shiffman, Hans Heinrich Wedemeyer, Thomas Berg, Eric Yoshida, Xavier Forns, Sandra Lovell, Barbara Da Silva-Tillmann, Christine A Collins, Andrew L Campbell, Thomas Podsadecki On behalf of the TURQUOISE-II investigators
|
| |
|
|
|
|
|
